Abstract:Objective To investigate the effect of monoamine oxidase-A (MAO-A) in biliary tract cancers (BTCs) on the immunity of tumor-associated macrophages.Methods MAO-A expression plasmid and control plasmid were constructed and transiently transfected into BTC cell lines respectively.Macrophages were derived from peripheral blood mononuclear cells donated by healthy volunteers.Macrophages were then cocultured with aforementioned transfected cancer cell lines for 48 h respectively,Western blotting and enzyme linked immunosorbent assay (ELISA) were applied to assess the expression of immune effector proteins and the excretion of cytokines from cocultured macrophages.24 h priming of macrophages with human recombinant interferon-γ (IFN-γ) were performed after their first stage of coculture;then the second stage of coculture with corresponding transfected cancer cell lines for 48 h were followed.Flow cytometry was employed to detect necrosis and apotosis of cancer cells induced by cocultured macrophages.Results The expression of MAO-A was down-regulated in BTC cell lines,which polarized the cocultured macrophages into M2 type tumor-associated macrophages,and promoted their excretion of interleukin (IL)-10 and expression of PD-L1,while suppressed their excretion of tumor necrosis factor-α (TNF-α),IL-1β and IL-12p70 (18.8±2.3 vs.31.7±1.9,75.0±0.4 vs.150.2±17.0 and 49.1 ± 15.2 vs.135.2 ± 1.0,respectively,P ＜ 0.05),as well as the expression of Human leukocyte antigen-DR (HLA-DR).On the contrary,however,macrophages cocultured with MAO-A overexpressing BTC cells exhibited pro-inflammatory phenotype (M1 type) which opposite to above suppressive immunity phenotype (M2 type).After priming of IFN-γ,macrophages cocultured with MAO-A overexpressing BTC cells induced tumor necrosis and apoptosis more effectively than those cocultured with control BTCcells [(84.85±5.66)％ vs.(1.56±0.46)％ and (76.73 ±6.31)％ vs.(1.28±0.57)％,respectively,P ＜ 0.05].Conclusion Down-regulation of MAO-A in BTC can promote the development of M2 type tumor-associated macrophages,while restoration of MAO-A in BTC can recover antitumor immunity of macrophages.Present study supports MAO-A as a promising target in the immunotherapy of BTC.

Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy

Targeting monoamine oxidase A for T cell–based cancer immunotherapy

Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulators

Mir-182 Targeting Reprograms Tumor-Associated Macrophages and Limits Breast Cancer Progression

Targeting tumor-associated macrophages to synergize tumor immunotherapy

Nanomaterials targeting tumor associated macrophages for cancer immunotherapy

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy.

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities

Blockade of C5a Receptor Unleashes Tumor-Associated Macrophage Antitumor Response and Enhances CXCL9-dependent CD8+ T Cell Activity

Effect of monoamine oxidase-A on the anti-tumor immunity of tumor-associated macrophages in biliary tract cancers

Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy

Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo.

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

Reprogramming Tumor Associated Macrophages Toward M1 Phenotypes with Nanomedicine for Anticancer Immunotherapy

Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy

Mechanistic studies of tumor-associated macrophage immunotherapy

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy

New insights into the role of macrophages in cancer immunotherapy

Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer